NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/21/2026
Back to search
Official data from USPTO
GANDEEVA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
GANDEEVA
ST13
US500000097981256Class
42, 44
Filing
97981256
Registration
8223463
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
49
Latest update
04/21/2026
Classification
Registered
Trademark type
Word
Nice classes
42, 44
Filing date
07/26/2022
Registration date
04/21/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/21/2026
Last transaction
04/21/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
01/17/2025
First use in commerce
01/17/2025
Drawing code
4
Owner type
03
Owner location
Seattle, WA, US
Examiner
BEAUDRY-TORRES, FAITH
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Gandeeva Therapeutics, Inc.
Representatives
Jessica L. Rothstein GOODWIN PROCTER LLP
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Drug discovery services; Scientific research; Medical oncology research; Scientific study and research in the fields of protein interactions and aberrant protein function; Biological research and analysis; Providing medical and scientific research information; Providing information about medical research via a website; Medical and scientific research in the field of cancer treatment and diagnosis; Medical and scientific research in the field of structural biologyartificial intelligence and machine learning; Software as a service (SaaS) services featuring software for bioinformatics data analysis; Pharmaceutical drug development services; Biochemical research and analysis; Providing information in the field of drug discovery via a website; Providing information in the field of structural biology via a website
Class 44
Providing medical information in the field of oncology; Providing medical information in the field of protein interactions and aberrant protein function; Providing pharmaceutical information; Medical analysis services for diagnostic and treatment purposes; Providing information in the field of medicine via a website; Providing information in the field of oncology via a website; providing information and commentary in the field of precision medicine
Publications
History of USPTO decisions and trademark events.
49 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/21/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/29/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/29/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/05/2026
DPCC
DIVISIONAL PROCESSING COMPLETE
03/05/2026
EX5G
SOU EXTENSION 5 GRANTED
03/05/2026
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/04/2026
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/04/2026
EX4G
SOU EXTENSION 4 GRANTED
03/03/2026
IUAF
USE AMENDMENT FILED
09/26/2025
DRRR
DIVISIONAL REQUEST RECEIVED
09/26/2025
EXT5
SOU EXTENSION 5 FILED
09/26/2025
EXT4
SOU EXTENSION 4 FILED
09/26/2025
EISU
TEAS STATEMENT OF USE RECEIVED
09/26/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
09/26/2025
EEXT
SOU TEAS EXTENSION RECEIVED
09/26/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/25/2025
EX3G
SOU EXTENSION 3 GRANTED
03/25/2025
EXT3
SOU EXTENSION 3 FILED
03/25/2025
EEXT
SOU TEAS EXTENSION RECEIVED
03/24/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/22/2024
EX2G
SOU EXTENSION 2 GRANTED
08/22/2024
EXT2
SOU EXTENSION 2 FILED
08/22/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/22/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
03/20/2024
EX1G
SOU EXTENSION 1 GRANTED
03/19/2024
EXT1
SOU EXTENSION 1 FILED
03/19/2024
EEXT
SOU TEAS EXTENSION RECEIVED
03/19/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/26/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2023
PUBO
PUBLISHED FOR OPPOSITION
08/01/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/22/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
06/22/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/22/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
06/22/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/22/2023
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
06/12/2023
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
06/07/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/07/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/20/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
05/20/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/20/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
05/20/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/20/2023
DOCK
ASSIGNED TO EXAMINER
05/11/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/17/2022
NWAP
NEW APPLICATION ENTERED
07/29/2022
Continuous trademark protection
Get notified about every new filing that threatens GANDEEVA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.